stars 1 stars 2 stars 3

Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual property estate to retain its leadership in the microRNA field. Regulus is located in San Diego, California and is led by a seasoned executive team experienced in corporate management, business, science, drug discovery and development. Regulus' scientific advisory board consists of world-class scientists and some of the foremost authorities in the field of microRNA research.

Regulus Therapeutics Questions

The Regulus Therapeutics annual revenue was $6.3 million in 2026.

Christopher Aker is the Senior Vice President and General Counsel of Regulus Therapeutics.

5 people are employed at Regulus Therapeutics.

Regulus Therapeutics is based in San Diego, California.

The NAICS codes for Regulus Therapeutics are [325, 541, 54171, 32, 5417, 541711, 33, 54].

The SIC codes for Regulus Therapeutics are [87, 37, 283, 28].

Top Regulus Therapeutics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users